Weekday calcipotriene extends psoriasis remission

December 1998
Modern Medicine;Dec98, Vol. 66 Issue 12, p42
Presents an abstract of the study `Calcipotriene ointment and halobetasol ointment in the long-term treatment of psoriasis: Effects on the duration of improvement,' by M. Lebwohl, A. Yoles, K. Lombardi, et al., which appeared in the `Journal of American Academic Dermatol,' dated September 1998.


Related Articles

  • Psoriasis: Flaky is only an adjective for piecrusts. Schaefer, Ingrid K. // Dermatology Times;Nov97 Supplement, Vol. 18 Issue 11, pS3 

    Editorial. Contemplates on the advances in psoriasis care. Effectiveness of over-the-counter remedies on psoriasis; Challenge for manufacturers to come up with a more effective treatment for proriasis.

  • FDA okays psoriasis indication for a cyclosporine.  // Dermatology Times;Nov97 Supplement, Vol. 18 Issue 11, pS25 

    Presents highlights of the Neoral labeling related top psoriasis. Considerations before initiating treatment with the drug; Initial recommended dose for patients with psoriasis; Cautions against the use of Neoral for longer than a year.

  • Patient Education Critical Factor in Successful Tazarotene Use. Moore, Ian J.S. // Dermatology Times;Feb98, Vol. 19 Issue 2, p45 

    States that tazarotene can be used successfully as a first-line treatment in psoriatic patients when they are properly instructed about its use. Factors to consider in prescribing the drug for psoriasis treatment; Common side effects of psoriatic treatment; How to manage the side effects of...

  • Psoriasis solution. Segell, Michael // Cosmopolitan;Sep95, Vol. 219 Issue 3, p94 

    Suggests a treatment for the skin disease called psoriasis. Estimated number of Americans afflicted with psoriasis; Cause of disease; Experimental therapy that may lead to discovery of drug for disease.

  • A New Calcipotriol/Betamethasone Formulation with Rapid Onset of Action was Superior to Monotherapy with Betamethasone Dipropionate or Calcipotriol in Psoriasis Vulgaris. Douglas, W. S.; Poulin, Y.; Decroix, J.; Ortonne, J. P.; Mrowietz, U.; Gulliver, W.; Krogstad, A. L.; Larsen, F. G.; Iglesias, L.; Buckley, C.; Bibby, A. J. // Acta Dermato-Venereologica;Mar2002, Vol. 82 Issue 2, p131 

    In this study, we compared a new combination ointment containing both calcipotriol and betamethasone dipropionate with betamethasone dipropionate ointment (Diprosone[sup ®]) and calcipotriol ointment (Daivonex[sup ®]) in patients with psoriasis vulgaris; 1106 patients were randomized to...

  • Oral Tazarotene. Guttman, Cheryl // Dermatology Times;May2003, Vol. 24 Issue 5, p24 

    Focuses on the use of oral tazarotene in treating psoriasis. Side effects of the drug; Mechanism of action.

  • No Differences. Guttman, Cheryl // Dermatology Times;May2003, Vol. 24 Issue 5, p26 

    Focuses on the use of Alefacept (Amevive) in treating chronic plaque psoriasis. Candidates for systemic therapy or phototherapy; Side effects of the drug; Mechanism of action.

  • PSORIASIS BRIEFS.  // Dermatology Times;May2003, Vol. 24 Issue 5, p27 

    Presents news items related to psoriasis as of May 2003. Effectiveness of Alefacept in treating psoriasis; Promotion of psoriasis drug Donovex.

  • Soriatane Label Revised. Guttman, Cheryl // Dermatology Times;May2003, Vol. 24 Issue 5, p30 

    Focuses on the use of acitretin in treating psoriasis. Effectiveness of the drug; Contraindications; Usage.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics